Riskpilot← Back to searchSign inGet full accessNARVIK HELSEKLINIKK DA
DAActiveOrg 918307230Dronningens Gate 51, 8514 NarvikOther human health activities n.e.c. · NACE 8699Est. 20170 employees
Revenue 2024
NOK 291K
-3% vs 2023
EBITDA margin
0.0%
-102% vs 2023
Equity ratio
-204.2%
Financial strength
Net profit 2024
NOK 0
0 employees
| Revenue | NOK 291K | -3% |
| EBITDA | NOK -60 | -102% |
| Net profit | NOK 0 | — |
| Total assets | NOK 14K | -45% |
| Equity | NOK -29K | +0% |
| Employees | 0 | — |
Legal name
NARVIK HELSEKLINIKK DA
Org number
918307230
Legal form
Ansvarlig Selskap Med Delt Ansvar
NACE code
8699 · Other human health activities n.e.c.
Founded
3. januar 2017
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Etablering og drift av en felles plattform for profilering. Deltakerne er selvstendig næringsdrivende lokalisert til et fellesskap i dr.gt. 5 i narvik. Narvik helseklinikk er et non profitt selskap hvor eierne har valgt et fellesskap for etablering av felles profil på klinikkens fasade. Kostnadene til felles profilering fordeles ved at hvert kontor/eier betaler inn et a konto beløp. Eierne har et solidarisk ansvar for at virksomhetens inntekter sikres, lik virksomhetens kostnader, som er begrenset til overnevnte formål.
Address
Dronningens Gate 51, 8514 Narvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 7 | 5 | 56 | 203 | 241 | 298 | 291 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 1 | −1 | 17 | −23 | −24 | 3 | −0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 | −1 | 17 | −23 | −24 | 3 | −0 |
| Net financials | 0 | 0 | 0 | −0 | −0 | −3 | 0 |
| Profit before tax | 1 | −1 | 17 | −23 | −24 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 | −1 | 17 | −23 | −24 | 0 | 0 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 2 | 1 | 23 | 9 | 14 | 26 | 14 |
| Equity | 2 | 1 | 18 | −5 | −29 | −29 | −29 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 5 | 14 | 43 | 54 | 43 |
| Total debt | 0 | 0 | 5 | 14 | 43 | 54 | 43 |
EBITDA margin
-0.0%
This company
15.8%
Market median
-100% vs market
20182024
Equity ratio
-204.2%
This company
38.2%
Market median
-635% vs market
20182024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20182024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20182024
Asset turnover
20.73×
This company
1.12×
Market median
+1751% vs market
20182024
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 0.0% | 0.0% | 2021 | |
JS FYSIOTERAPI AS | Company | 0.0% | 0.0% | 2021 |
NARVIKKIROPRAKTOREN AS | Company | 0.0% | 0.0% | 2021 |
GELIS EIENDOM AS | Company | 0.0% | 0.0% | 2021 |
| Individual | 0.0% | 0.0% | 2021 | |
| Individual | 0.0% | 0.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NARVIK HELSEKLINIKK DA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|